M. Presti

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

Matti Aapro, F.H. van Wijk, Giorgio Bolis et al. · Annals of Oncology · 2003 · 200 citations · Full text

Medicine, Gynecology, Oncology +8

Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P)

Giorgio Bolis, Nicoletta Colombo, S. Pecorelli et al. · Annals of Oncology · 1995 · 173 citations · Full text

Medicine, Gynecology, Oncology +11

Randomized Trial in Advanced Ovarian Cancer Comparing Cisplatin and Carboplatin

C. Mangioni, Giorgio Bolis, S. Pecorelli et al. · JNCI Journal of the National Cancer Institute · 1989 · 143 citations

Medicine, Gynecology, Oncology +14

Carboplatin Alone vs Carboplatin plus Epidoxorubicin as Second-Line Therapy for Cisplatin- or Carboplatin-Sensitive Ovarian Cancer

Giorgio Bolis, Giovanna Scarfone, Giorgio Giardina et al. · Gynecologic Oncology · 2001 · 88 citations

Medicine, Oncology, Pharmacology +10

Striatal opioid peptide content in an animal model of spontaneous stereotypic behavior

M. Presti, Mark H. Lewis · Behavioural Brain Research · 2004 · 82 citations

Life Sciences, Neurobiology, Neuroscience +15